ACS
AGN

Archford Capital Strategies’s Allergan plc AGN Stock Holding History

Archford Capital Strategies’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20
Closed -$5K – 683
2017
Q1 		$5K Hold
20
– – ﹤0.01% 480
2016
Q4 		$4K Sell
20
-15
-43% -$3.11K ﹤0.01% 444
2016
Q3 		$8K Buy
+35
New +$8.55K ﹤0.01% 389
2015
Q4 		– Sell
-254
Closed -$69K – 863
2015
Q3 		$69K Hold
254
– – 0.05% 171
2015
Q2 		$77K Sell
254
-2
-0.8% -$597 0.05% 167
2015
Q1 		$76.2K Buy
256
+37
+17% +$10.5K 0.05% 173
2014
Q4 		$56K Buy
219
+113
+107% +$28.2K 0.04% 196
2014
Q3 		$26K Hold
106
– – 0.02% 267
2014
Q2 		$23.6K Hold
106
– – 0.02% 296
2014
Q1 		$21.8K Buy
+106
New +$21K 0.02% 311

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Archford Capital Strategies's AGN Position: Q2 2017 in Review

Archford Capital Strategies sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 20 shares — an estimated $5K sold.

Archford Capital Strategies first reported a position in AGN in Q1 2014 and held it in 10 quarters. The position peaked at $77K in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Archford Capital Strategies reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Archford Capital Strategies sold 20 Allergan plc shares in Q2 2017, an estimated $5K.
  • Archford Capital Strategies first reported a position in Allergan plc in Q1 2014 and held it in 10 quarters.
  • Archford Capital Strategies's Allergan plc position peaked at $77K in Q2 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Archford Capital Strategies's 13F filing for Q2 2017, filed 18 Aug 2017.